false 0001849380 0001849380 2024-06-03 2024-06-03 0001849380 ONMD:ClassCommonStock0.0001ParValuePerShareMember 2024-06-03 2024-06-03 0001849380 ONMD:RedeemableWarrantsEachExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember 2024-06-03 2024-06-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 3, 2024

 

ONEMEDNET CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   001-40386   86-2076743

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification Number)

 

6385 Old Shady Oak Road, Suite 250

Eden Prairie, MN 55344

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: 800-918-7189

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Class A Common Stock, $0.0001 par value per share   ONMD   The Nasdaq Stock Market LLC
Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share   ONMDW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Section 4 – Matters Related to Accountants and Financial Statements

 

Item 4.01 Changes in Registrant’s Certifying Accountant

 

Appointment of Independent Registered Public Accounting Firm

 

As previously reported on Form 8-K by OneMedNet Corporation (the “Company”) on May 10, 2024, on May 6, 2024, the Company dismissed BF Borgers CPA PC (“Borgers”) as its independent registered public accounting firm following the Securities and Exchange Commission (the “SEC”) announcement that it had settled charges against Borgers that it failed to conduct audits of a number of public companies in accordance with the standards of the Public Company Accounting Oversight Board (the “PCAOB”) on May 3, 2024. As part of the settlement, Borgers agreed to a permanent ban on appearing or practicing before the SEC (the “Order”).

 

On June 3, 2024, the Company appointed WithumSmith+Brown, PC (“WS+B”) as its new independent registered public accounting firm to audit and review the Company’s financial statements. During the two most recent fiscal years ended December 31, 2023 and 2022 and any subsequent interim periods through the date hereof prior to the engagement of WS+B, neither the Company, nor someone on its behalf, has consulted WS+B regarding:

 

  (i) either: the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and either a written report was provided to the Company or oral advice was provided that the new independent registered public accounting firm concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or
     
  (ii) any matter that was either the subject of a disagreement as defined in paragraph 304(a)(1)(iv) of Regulation S-K or a reportable event as described in paragraph 304(a)(1)(v) of Regulation S-K.

 

Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

 

(a) At this time, the Company is not aware of any basis to believe that any previously issued financial statements should not be relied upon because of an error in such financial statements. However, the Company continues to assess its financial statements in light of the events described in Item 4.01(a) herein.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ONEMEDNET CORPORATION
     
Date: June 4, 2024    
  By: /s/ Aaron Green
  Name: Aaron Green
  Title: Chief Executive Officer

 

 

v3.24.1.1.u2
Cover
Jun. 03, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 03, 2024
Entity File Number 001-40386
Entity Registrant Name ONEMEDNET CORPORATION
Entity Central Index Key 0001849380
Entity Tax Identification Number 86-2076743
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 6385 Old Shady Oak Road
Entity Address, Address Line Two Suite 250
Entity Address, City or Town Eden Prairie
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55344
City Area Code 800
Local Phone Number 918-7189
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Class A Common Stock, $0.0001 par value per share  
Title of 12(b) Security Class A Common Stock, $0.0001 par value per share
Trading Symbol ONMD
Security Exchange Name NASDAQ
Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share  
Title of 12(b) Security Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
Trading Symbol ONMDW
Security Exchange Name NASDAQ
Grafico Azioni OneMedNet (NASDAQ:ONMDW)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di OneMedNet
Grafico Azioni OneMedNet (NASDAQ:ONMDW)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di OneMedNet